LifeMD, Inc. financial data

Symbol
LFMD, LFMDP on Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
Location
236 Fifth Avenue, Suite 400, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
CONVERSION LABS, INC. (to 2/22/2021), Immudyne, Inc. (to 6/19/2018)
Latest financial report
Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 95.1 % +54.1%
Quick Ratio 5.18 % -56.5%
Debt-to-equity -2.78K % -743%
Return On Equity 7.83K % +3315%
Return On Assets -35.1 % +58.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43.3M shares +14%
Common Stock, Shares, Outstanding 41.8M shares +20.6%
Entity Public Float 112M USD +126%
Common Stock, Value, Issued 419K USD +20.6%
Weighted Average Number of Shares Outstanding, Basic 42M shares +21.9%
Weighted Average Number of Shares Outstanding, Diluted 42M shares +21.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 193M USD +42.2%
Cost of Revenue 20M USD +13.5%
Selling and Marketing Expense 97.6M USD +32.7%
General and Administrative Expense 68.3M USD +50.8%
Operating Income (Loss) -19.3M USD +14.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.24M USD +0.73%
Income Tax Expense (Benefit) 233K USD
Net Income (Loss) Attributable to Parent -22.5M USD +21.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.6M USD +146%
Accounts Receivable, after Allowance for Credit Loss, Current 6.05M USD +36.9%
Inventory, Net 2.65M USD -30.2%
Other Assets, Current 2.24M USD +71.6%
Assets, Current 48.7M USD +95.5%
Property, Plant and Equipment, Net 1.42M USD +234%
Operating Lease, Right-of-Use Asset 6.75M USD +745%
Intangible Assets, Net (Excluding Goodwill) 4.92M USD
Goodwill 8M USD +41.5%
Assets 72.6M USD +78.3%
Accounts Payable, Current 15.9M USD +64.6%
Accrued Liabilities, Current 21M USD +35.6%
Contract with Customer, Liability, Current 5.5M USD +267%
Liabilities, Current 59M USD +81.3%
Operating Lease, Liability, Noncurrent 6.51M USD +3734%
Liabilities 78.5M USD +51.6%
Retained Earnings (Accumulated Deficit) -235M USD -12.2%
Stockholders' Equity Attributable to Parent -7.72M USD +39.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -5.96M USD +46.3%
Liabilities and Equity 72.6M USD +78.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 5.2M USD
Net Cash Provided by (Used in) Financing Activities -1.05M USD -109%
Net Cash Provided by (Used in) Investing Activities -2.19M USD -20.9%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 41.9M shares +20.6%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.96M USD -74%
Interest Paid, Excluding Capitalized Interest, Operating Activities 645K USD +136%
Deferred Tax Assets, Valuation Allowance 40.9M USD +15.1%
Deferred Tax Assets, Gross 40.9M USD +15.1%
Operating Lease, Liability 6.91M USD +672%
Depreciation 65.9K USD +38.3%
Payments to Acquire Property, Plant, and Equipment 176K USD +422%
Operating Lease, Liability, Current 403K USD -44.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.34M USD +1852%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.23M USD +103%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +55.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.36M USD +12442%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.24M USD
Deferred Tax Assets, Operating Loss Carryforwards 23.1M USD +7.83%
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 937K USD
Operating Lease, Payments 227K USD +0.1%
Additional Paid in Capital 227M USD +15.5%
Amortization of Intangible Assets 984K USD -0.09%
Share-based Payment Arrangement, Expense 3.3M USD 0%
Interest Expense 2.19M USD -22.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%